Alosetron (Lotronex) for treatment of irritable bowel syndrome.
D002243:Carbolines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D003248:Constipation / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005252:Fees, Pharmaceutical; D006801:Humans; D007408:Intestinal Absorption; D016032:Randomized Controlled Trials as Topic; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D002243:Carbolines; D012702:Serotonin Antagonists; C090840:alosetron